As on Wednesday, Caribou Biosciences Inc (NASDAQ: CRBU) started slowly as it slid -4.14% to $1.62, before settling in for the price of $1.69 at the close. Taking a more long-term approach, CRBU posted a 52-week range of $0.66-$3.54.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -33.41%. Meanwhile, its Annual Earning per share during the time was -33.41%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.38%. This publicly-traded company’s shares outstanding now amounts to $93.47 million, simultaneously with a float of $82.78 million. The organization now has a market capitalization sitting at $151.42 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1571, while the 200-day Moving Average is $1.6027.
Caribou Biosciences Inc (CRBU) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Caribou Biosciences Inc’s current insider ownership accounts for 11.44%, in contrast to 37.02% institutional ownership. According to the most recent insider trade that took place on Mar 14 ’25, this organization’s President and CEO bought 20,000 shares at the rate of 1.02, making the entire transaction reach 20,400 in total value, affecting insider ownership by 3,369,395. Preceding that transaction, on Feb 21 ’25, Company’s Chief Legal Officer sold 3,564 for 1.35, making the whole transaction’s value amount to 4,811. This particular insider is now the holder of 443,502 in total.
Caribou Biosciences Inc (CRBU) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
Caribou Biosciences Inc’s EPS increase for this current 12-month fiscal period is 3.38% and is forecasted to reach -1.43 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.17% through the next 5 years, which can be compared against the -33.41% growth it accomplished over the previous five years trading on the market.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Let’s observe the current performance indicators for Caribou Biosciences Inc (CRBU). It’s Quick Ratio in the last reported quarter now stands at 5.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.30.
In the same vein, CRBU’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.70, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.43 at the market close of one year from today.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Through scrutinizing the latest numbers posted by the [Caribou Biosciences Inc, CRBU], it can be observed that its last 5-days Average volume of 1.07 million was lower the volume of 1.56 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 28.48% While, its Average True Range was 26.17.
Raw Stochastic average of Caribou Biosciences Inc (CRBU) in the period of the previous 100 days is set at 0.00%, which indicates a major rise in contrast to 0.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1000 that was lower than 0.1747 volatility it exhibited in the past 100-days period.
